The primary objective of this pilot study is to assess effects of Hyoscine Butylbromide
(HBB) 20 mg in comparison to placebo, when used as needed, as measured by the subject's
assessment of intensity of abdominal pain associated with cramping (APC) in the treatment of
two episodes.
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
202.839.01014 Boehringer Ingelheim Investigational Site, Westlake Village, California, United States
202.839.01003 Boehringer Ingelheim Investigational Site, Hollywwod, Florida, United States
202.839.01001 Boehringer Ingelheim Investigational Site, Jupiter, Florida, United States
202.839.01002 Boehringer Ingelheim Investigational Site, Jupiter, Florida, United States
202.839.01017 Boehringer Ingelheim Investigational Site, Rockford, Illinois, United States
202.839.01005 Boehringer Ingelheim Investigational Site, Indianapolis, Indiana, United States
202.839.01019 Boehringer Ingelheim Investigational Site, Chevy Chase, Maryland, United States
202.839.01009 Boehringer Ingelheim Investigational Site, Boston, Massachusetts, United States
202.839.01004 Boehringer Ingelheim Investigational Site, Lebanon, New Hampshire, United States
202.839.01011 Boehringer Ingelheim Investigational Site, Toms River, New Jersey, United States
202.839.01008 Boehringer Ingelheim Investigational Site, Lake Success, New York, United States
202.839.01015 Boehringer Ingelheim Investigational Site, Cleveland, Ohio, United States
202.839.01021 Boehringer Ingelheim Investigational Site, Norman, Oklahoma, United States
202.839.01010 Boehringer Ingelheim Investigational Site, Oklahoma City, Oklahoma, United States
202.839.01013 Boehringer Ingelheim Investigational Site, Philadelphia, Pennsylvania, United States
202.839.01006 Boehringer Ingelheim Investigational Site, San Antonio, Texas, United States
202.839.01012 Boehringer Ingelheim Investigational Site, San Antonio, Texas, United States
202.839.01007 Boehringer Ingelheim Investigational Site, Virginia Beach, Virginia, United States
202.839.01020 Boehringer Ingelheim Investigational Site, Milwaukee, Wisconsin, United States